News Roundup: Mattel, Inc. (NASDAQ:MAT); Calpine Corporation (NYSE:CPN) And Actavis Plc (NYSE:ACT)

Boston, MA, 02/20/2014 – Mattel, Inc. (NASDAQ:MAT)‘s decision to bring Barbie in this month’s Sports Illustrated 50th swimsuit issue has fallen in place amd contributing to its success enormously. Post the Barbie’s swimsuit appearance in the magazine, caused a stir and became a point of debate in social media if the feature is appropriate. But, it also helped Mattel to spike its sales as more than half of the version of Barbie sold out within first two days. Also, the doll is now being sold at a price $59.99, three times higher than its original price of $19.99 after the buyers rushed to eBay Inc (NASDAQ:EBAY). Mattel, Inc. (NASDAQ:MAT) is the world’s largest toymaker and is popular to float some publicity stunts in every few years to give a boost to the image of Barbie.

Calpine Corporation (NYSE:CPN) stands downgraded by the analyst at UBS. The revised rating now is ‘Neutral’ from the earlier ‘Buy’ rating. The analysts have cited that there are few catalysts like lower capacity in Texas and limited EBITDA growth in California for the downgrade. UBS has placed a price target of $22 for the company, reflecting an upside potential of 10% from its current trading price. Last week Calpine had failed to meet the expectations of the market both in terms of revenue and EPS for its fourth quarter results. Calpine Corporation (NYSE:CPN) widely missed the EPS expectation of -$0.05 as against its -$0.23. Revenues at $1.44 billion too trailed by as much as $150 million.

Actavis Plc (NYSE:ACT) is booming with several positivities ahead of its quarterly earnings today. On Wednesday, Actavis gained momentum after several analysts chose to show optimistic outlook over its acquisition of Forest Labs.Among the prominent analysts taking view of it was Goldman Sachs, which upgraded its stock to ‘Buy’, citing that the company is among the fastest growing firms. At the same time, Buckingham and Barcap have also set their price target for Actavis Plc (NYSE:ACT) at $250, a way above its current price of $210.

Like it? Share it!

Leave A Response